Pro Medicus Future Growth
Future criteria checks 5/6
Pro Medicus is forecast to grow earnings and revenue by 20.3% and 18% per annum respectively. EPS is expected to grow by 20.4% per annum. Return on equity is forecast to be 45.1% in 3 years.
Key information
20.3%
Earnings growth rate
20.4%
EPS growth rate
Healthcare Services earnings growth | 26.1% |
Revenue growth rate | 18.0% |
Future return on equity | 45.1% |
Analyst coverage | Good |
Last updated | 16 Apr 2024 |
Recent future growth updates
Recent updates
Here's Why We Think Pro Medicus (ASX:PME) Might Deserve Your Attention Today
Jan 15Investors Should Be Encouraged By Pro Medicus' (ASX:PME) Returns On Capital
Dec 10Here's Why Pro Medicus (ASX:PME) Has Caught The Eye Of Investors
Oct 09Why The 47% Return On Capital At Pro Medicus (ASX:PME) Should Have Your Attention
Aug 12Here's Why We Think Pro Medicus (ASX:PME) Is Well Worth Watching
Jul 08Returns on Capital Paint A Bright Future For Pro Medicus (ASX:PME)
May 09Is Now The Time To Put Pro Medicus (ASX:PME) On Your Watchlist?
Apr 02Pro Medicus (ASX:PME) Is Achieving High Returns On Its Capital
Jan 25We Ran A Stock Scan For Earnings Growth And Pro Medicus (ASX:PME) Passed With Ease
Dec 13Returns on Capital Paint A Bright Future For Pro Medicus (ASX:PME)
Oct 26Here's Why We Think Pro Medicus (ASX:PME) Is Well Worth Watching
Sep 14Investors Should Be Encouraged By Pro Medicus' (ASX:PME) Returns On Capital
Jul 06Here's Why We Think Pro Medicus (ASX:PME) Is Well Worth Watching
Jun 15Do Pro Medicus's (ASX:PME) Earnings Warrant Your Attention?
Mar 16Investors Should Be Encouraged By Pro Medicus' (ASX:PME) Returns On Capital
Feb 23Is Now The Time To Put Pro Medicus (ASX:PME) On Your Watchlist?
Oct 26Pro Medicus (ASX:PME) Knows How To Allocate Capital Effectively
Aug 13Do Pro Medicus's (ASX:PME) Earnings Warrant Your Attention?
Jul 26Pro Medicus (ASX:PME) Is Investing Its Capital With Increasing Efficiency
May 07Pro Medicus Limited's (ASX:PME) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
Mar 15This Insider Has Just Sold Shares In Pro Medicus Limited (ASX:PME)
Feb 20Pro Medicus Limited Just Missed EPS By 14%: Here's What Analysts Think Will Happen Next
Feb 18Is Pro Medicus (ASX:PME) The Next Multi-Bagger?
Feb 01How Much Did Pro Medicus' (ASX:PME) CEO Pocket Last Year?
Jan 12Should You Be Adding Pro Medicus (ASX:PME) To Your Watchlist Today?
Dec 28Pro Medicus (ASX:PME) Has Rewarded Shareholders With An Exceptional 825% Total Return On Their Investment
Dec 11Is Pro Medicus Limited's (ASX:PME) Shareholder Ownership Skewed Towards Insiders?
Nov 26Pro Medicus's (ASX:PME) Earnings Are Growing But Is There More To The Story?
Aug 09What Kind Of Shareholders Hold The Majority In Pro Medicus Limited's (ASX:PME) Shares?
Aug 09Does Pro Medicus (ASX:PME) Have The DNA Of A Multi-Bagger?
Jul 21How Much Are Pro Medicus Limited (ASX:PME) Insiders Taking Off The Table?
Jul 03Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
6/30/2026 | 250 | 131 | 119 | 128 | 13 |
6/30/2025 | 204 | 103 | 96 | 103 | 13 |
6/30/2024 | 160 | 79 | 75 | 81 | 13 |
12/31/2023 | 142 | 70 | 65 | 71 | N/A |
9/30/2023 | 134 | 65 | 60 | 67 | N/A |
6/30/2023 | 125 | 61 | 56 | 63 | N/A |
3/31/2023 | 115 | 56 | 51 | 59 | N/A |
12/31/2022 | 106 | 51 | 47 | 55 | N/A |
9/30/2022 | 100 | 48 | 50 | 58 | N/A |
6/30/2022 | 93 | 44 | 53 | 62 | N/A |
3/31/2022 | 87 | 41 | 47 | 55 | N/A |
12/31/2021 | 81 | 38 | 41 | 49 | N/A |
9/30/2021 | 74 | 34 | 36 | 44 | N/A |
6/30/2021 | 68 | 31 | 31 | 39 | N/A |
3/31/2021 | 64 | 28 | 27 | 36 | N/A |
12/31/2020 | 59 | 25 | 24 | 32 | N/A |
9/30/2020 | 58 | 24 | 24 | 32 | N/A |
6/30/2020 | 57 | 23 | 24 | 31 | N/A |
3/31/2020 | 55 | 23 | 25 | 33 | N/A |
12/31/2019 | 54 | 22 | 27 | 34 | N/A |
9/30/2019 | 52 | 21 | 22 | 30 | N/A |
6/30/2019 | 50 | 19 | 17 | 25 | N/A |
3/31/2019 | 47 | 17 | N/A | N/A | N/A |
12/31/2018 | 43 | 16 | 7 | 14 | N/A |
9/30/2018 | 39 | 13 | 7 | 14 | N/A |
6/30/2018 | 34 | 10 | 7 | 14 | N/A |
3/31/2018 | 33 | 9 | N/A | N/A | N/A |
12/31/2017 | 32 | 8 | 8 | 15 | N/A |
9/30/2017 | 32 | 9 | N/A | 15 | N/A |
6/30/2017 | 32 | 9 | N/A | 15 | N/A |
3/31/2017 | 30 | 9 | N/A | 13 | N/A |
12/31/2016 | 28 | 8 | N/A | 12 | N/A |
9/30/2016 | 28 | 7 | N/A | 11 | N/A |
6/30/2016 | 28 | 6 | N/A | 11 | N/A |
3/31/2016 | 25 | 5 | N/A | 9 | N/A |
12/31/2015 | 23 | 5 | N/A | 8 | N/A |
9/30/2015 | 20 | 4 | N/A | 6 | N/A |
6/30/2015 | 17 | 3 | N/A | 4 | N/A |
3/31/2015 | 17 | 3 | N/A | 4 | N/A |
12/31/2014 | 17 | 3 | N/A | 4 | N/A |
9/30/2014 | 16 | 2 | N/A | 4 | N/A |
6/30/2014 | 14 | 2 | N/A | 4 | N/A |
12/31/2013 | 11 | 1 | N/A | 6 | N/A |
9/30/2013 | 11 | -1 | N/A | 5 | N/A |
6/30/2013 | 11 | -3 | N/A | 4 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: PME's forecast earnings growth (20.3% per year) is above the savings rate (2.2%).
Earnings vs Market: PME's earnings (20.3% per year) are forecast to grow faster than the Australian market (13.4% per year).
High Growth Earnings: PME's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: PME's revenue (18% per year) is forecast to grow faster than the Australian market (4.7% per year).
High Growth Revenue: PME's revenue (18% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: PME's Return on Equity is forecast to be very high in 3 years time (45.1%).